Immunity and Hypertension-Reference-Cited by-同舟云学术

Immunity and Hypertension

Published:2020-06-25 Issue:1 Volume:231 Page:
ISSN:1748-1708
Container-title:Acta Physiologica
language:en
Short-container-title:Acta Physiol

Author:

Zhang Rong M.¹,McNerney Kyle P.²,Riek Amy E.¹,Bernal‐Mizrachi Carlos¹³⁴^ORCID

Affiliation:

1. Department of Medicine Division of Endocrinology, Metabolism, and Lipid Research Washington University School of Medicine St. Louis MO USA

2. Department of Pediatrics Washington University School of Medicine St. Louis MO USA

3. Department of Cell Biology and Physiology Washington University School of Medicine St. Louis MO USA

4. Department of Medicine VA Medical Center St. Louis MO USA

Funder

Center for Scientific Review

Publisher

Wiley

Subject

Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apha.13487

Reference173 articles.

1. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012;Nwankwo T;NCHS Data Brief,2013

2. Evidence for an initial, thymus independent and a chronic, thymus dependent phase of DOCA and salt hypertension in mice;Svendsen UG;Acta Pathol Microbiol Scand A,1976

3. Role of the Immune System in Hypertension

4. Vascular Inflammatory Cells in Hypertension

5. Autoimmune Factors Associated with Infarction of the Kidney

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paricalcitol prevents renal tubular injury induced by ischemia-reperfusion: Role of oxidative stress, inflammation and AT1R;Molecular and Cellular Endocrinology;2024-12

2. The role of microbiota and oxidative stress axis and the impact of intravenous immunoglobulin in systemic lupus erythematosus;Autoimmunity Reviews;2024-09

3. The role of ACE2 in RAS axis on microglia activation in Parkinson’s disease;Neuroscience;2024-08

4. Resolution of inflammation, an active process to restore the immune microenvironment balance: A novel drug target for treating arterial hypertension;Ageing Research Reviews;2024-08

5. Use of angiotensin‑converting enzyme inhibitors in gynecological cancers: Pathways and mechanisms involved (Review);World Academy of Sciences Journal;2024-07-08